Skip to main content

CONTACT US

THANK YOU FOR
YOUR INTEREST.

For additional information or
to report an adverse event,
call Kala Pharmaceuticals, Inc. at
1-833-287-KALA (1-833-287-5252).

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit https://www.fda.gov/medwatch,
or call 1-800-FDA-1088.

Important Safety
Information

EYSUVIS should not be used if you have a viral infection in your eye. Talk to your doctor before using EYSUVIS if you think you may have a viral, bacterial, or fungal eye infection.

Your doctor should examine your eyes before prescribing EYSUVIS, to check for increased eye pressure or damage to the surface of the eye. Consult your doctor if pain, redness, itching, or inflammation develops or gets worse.

Wash your hands well before each use. Do not allow the dropper tip to touch any surface, as this may contaminate the suspension. Shake the bottle for two to three seconds before using. If a dose is missed, take the missed dose when remembered.

Remove contact lenses before using EYSUVIS; they may be reinserted 15 minutes later.

The most common adverse drug reaction following the use of EYSUVIS for two weeks was instillation site pain, which was reported in 5% of patients.

Indication

EYSUVIS is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.

Please see full Prescribing Information.